Trial Profile
EFFICACY AND SAFETY OF INTRAMUSCULAR NERIDRONATE IN OSTEOPOROTIC PATIENTS AFFECTED BY PARKINSON'S DISEASE [EFFICACIA E SICUREZZA DEL NERIDRONATO INTRAMUSCOLARE NEL TRATTAMENTO DELL OSTEOPOROSI IN PAZIENTI PARKINSONIANI]
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 26 Feb 2014
Price :
$35
*
At a glance
- Drugs Neridronic acid (Primary)
- Indications Hip fracture; Osteoporosis
- Focus Therapeutic Use
- 26 Feb 2014 New trial record